EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Crypt-Level Tight Junction Remodeling Is Associated with Disease Course and Clinical Outcomes in Inflammatory Bowel Disease

Efthymios P Tsounis iD, Christina Geramoutsou, Ploutarchos Pastras iD, Ioanna Aggeletopoulou iD, Pinelopi Bosgana, Theoni Lourida iD, Georgia Diamantopoulou, Sofia Ritsatou, Efthymios Koniaris iD, Gerassimos J Mantzaris iD, Vasiliki Zolota, Stelios F Assimakopoulos iD und 4 weitere

Cells · 2026

DOI: 10.3390/cells15080695 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cells, 2026. Verfasst von Efthymios P Tsounis und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of Gastroenterology, Department of Internal Medicine, University of Patras, 26504 Patras, Greece. Hauptthemen laut MEDLINE: Tight Junctions, Inflammatory Bowel Diseases, Disease Progression. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Intestinal barrier dysfunction is a hallmark of inflammatory bowel disease (IBD), yet the clinical significance of tight junction (TJ) remodeling remains unclear. We investigated whether alterations in the expression and localization of key TJ proteins are associated with disease activity and clinical outcomes in IBD.

Methods

This retrospective, single-center study included patients with Crohn’s disease (CD; n = 100), ulcerative colitis (UC; n = 120), and healthy controls (n = 80). Immunohistochemistry was used to assess the expression and subcellular localization of occludin and claudin-1 separately in surface (SE) and crypt epithelium (CR), with staining classified as predominantly membranous (regular) or cytoplasmic (irregular). The primary endpoint was IBD-related hospitalization. Secondary endpoints included surgery, initiation of biologic therapy, and clinical relapse. Logistic and Cox regression models were applied, and longitudinal changes were assessed in paired biopsies.

Results

Both occludin and claudin-1 were dysregulated in active disease, showing increased expression and cytoplasmic redistribution compared with remission and controls. TJ alterations were more pronounced in the CR and correlated with clinical, endoscopic, and histological activity. In CD, occludin CR overexpression was independently associated with hospitalization (aOR 1.010; p = 0.05) and surgery (aHR 1.013; p = 0.005), while irregular occludin CR staining was associated with initiation of biologic therapy (aOR 3.48; p = 0.03). In UC, increased occludin CR levels and irregular CR staining were associated with IBD-related hospitalization in multivariable analyses (aOR 1.014; p = 0.035 and aOR 2.78; p = 0.032, respectively). Higher occludin CR levels identified UC patients at increased risk of clinical relapse (aHR 1.012; p = 0.002). In paired biopsies (n = 127), TJ architecture—particularly in the CR—improved over time, with reduced expression and a shift toward membranous localization, most prominently in bio-experienced patients.

Conclusions

TJ remodeling, particularly crypt-level occludin dysregulation, is associated with disease activity and clinical outcomes, capturing a clinically relevant dimension of epithelial barrier dysfunction in IBD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tight JunctionsInflammatory Bowel DiseasesDisease ProgressionHumansFemaleMaleAdultOccludinClaudin-1Retrospective StudiesCrohn DiseaseColitis, UlcerativeMiddle AgedIntestinal Barrier FunctionIntestinal Mucosa

Stichwörter der Autor:innen

Crohn’s diseasebarrier dysfunctionclaudin-1clinical outcomesinflammatory bowel diseaseintestinal barrieroccludintight junctionulcerative colitis

Substanzen

OccludinClaudin-1

Autor:innen und Institutionen

  • Division of Gastroenterology, Department of Internal Medicine, University of Patras, 26504 Patras, Greece.
  • Department of Anatomy-Histology-Embryology, Medical School, University of Patras, 26504 Patras, Greece.
  • Department of Pathology, School of Medicine, University of Patras, 26504 Patras, Greece.
  • Department of Pathology-Anatomy, Hippocration Hospital of Athens, Athens Medical School, National and Kapodistrian University of Athens, 11528 Athens, Greece.
  • Department of Gastroenterology, White Cross Hospital, 11528 Athens, Greece.
  • Department of Gastroenterology, HYGEIA Hospital, 15123 Athens, Greece.

ORCID-Profile: Efthymios P Tsounis, Ploutarchos Pastras, Ioanna Aggeletopoulou, Theoni Lourida, Efthymios Koniaris, Gerassimos J Mantzaris, Stelios F Assimakopoulos, Vasiliki Bravou, Christos Triantos

Zitieren

APA

Tsounis, E. P., Geramoutsou, C., Pastras, P., Aggeletopoulou, I., Bosgana, P., Lourida, T., Diamantopoulou, G., Ritsatou, S., Koniaris, E., Mantzaris, G. J., Zolota, V., Assimakopoulos, S. F., Bravou, V., Thomopoulos, K., Theocharis, G., & Triantos, C. (2026). Crypt-Level Tight Junction Remodeling Is Associated with Disease Course and Clinical Outcomes in Inflammatory Bowel Disease. Cells. https://doi.org/10.3390/cells15080695

Vancouver

Tsounis EP, Geramoutsou C, Pastras P, Aggeletopoulou I, Bosgana P, Lourida T, et al. Crypt-Level Tight Junction Remodeling Is Associated with Disease Course and Clinical Outcomes in Inflammatory Bowel Disease. Cells. 2026. doi:10.3390/cells15080695

BibTeX
@article{Tsounis2026,
  author = {Tsounis, Efthymios P and Geramoutsou, Christina and Pastras, Ploutarchos and Aggeletopoulou, Ioanna and Bosgana, Pinelopi and Lourida, Theoni and Diamantopoulou, Georgia and Ritsatou, Sofia and Koniaris, Efthymios and Mantzaris, Gerassimos J and Zolota, Vasiliki and Assimakopoulos, Stelios F and Bravou, Vasiliki and Thomopoulos, Konstantinos and Theocharis, Georgios and Triantos, Christos},
  title = {Crypt-Level Tight Junction Remodeling Is Associated with Disease Course and Clinical Outcomes in Inflammatory Bowel Disease},
  journal = {Cells},
  year = {2026},
  doi = {10.3390/cells15080695}
}
Kostenlos starten →